BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1
21 results:

  • 1. Uterine Tumors Resembling ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases.
    Watrowski R; Palumbo M; Guerra S; Gallo A; Zizolfi B; Giampaolino P; Bifulco G; Di Spiezio Sardo A; De Angelis MC
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276058
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
    Qijun C; Wei W; Cheng W; Dongni L
    Hum Pathol; 2024 Jan; 143():33-41. PubMed ID: 38000680
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Uterine Tumor Resembling ovarian Sex Cord Tumors: 23 Cases Indicating Molecular Heterogeneity With Variable Biological Behavior.
    Bi R; Yao Q; Ji G; Bai Q; Li A; Liu Z; Cheng Y; Tu X; Yu L; Chang B; Huang D; Ge H; Zuo K; Li H; Chang H; Cai X; Jiang W; Zhou X; Yang W
    Am J Surg Pathol; 2023 Jul; 47(7):739-755. PubMed ID: 37132508
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ncoa1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
    Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
    Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Uterine Tumor Resembling ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review.
    Yin X; Wang M; He H; Ru G; Zhao M
    Int J Gynecol Pathol; 2023 Jan; 42(1):54-62. PubMed ID: 35081070
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
    Ye S; Wu J; Yao L; He J
    J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.
    Mei S; Ge S; Wang J; Li H; Jing X; Liang K; Zhang X; Xue C; Zhang C; Zhang T
    J Pathol Clin Res; 2021 Mar; 7(2):154-164. PubMed ID: 33416213
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1-rearranged uterine sarcoma with variable sex-cord differentiation.
    Kao YC; Lee JC
    Genes Chromosomes Cancer; 2021 Mar; 60(3):180-189. PubMed ID: 33099842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Uterine Tumor Resembling ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent ncoa1-3 Rearrangement.
    Goebel EA; Hernandez Bonilla S; Dong F; Dickson BC; Hoang LN; Hardisson D; Lacambra MD; Lu FI; Fletcher CDM; Crum CP; Antonescu CR; Nucci MR; Kolin DL
    Am J Surg Pathol; 2020 Jan; 44(1):30-42. PubMed ID: 31464709
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
    Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
    Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
    Katoh M
    Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Autocrine production of interleukin-6 confers ovarian cancer cells resistance to tamoxifen via ER isoforms and SRC-1.
    Wang Y; Qu Y; Zhang XL; Xing J; Niu XL; Chen X; Li ZM
    Mol Cell Endocrinol; 2014 Feb; 382(2):791-803. PubMed ID: 24189439
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. STAMP alters the growth of transformed and ovarian cancer cells.
    He Y; Blackford JA; Kohn EC; Simons SS
    BMC Cancer; 2010 Apr; 10():128. PubMed ID: 20374646
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
    Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
    Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
    Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
    Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
    Hussein-Fikret S; Fuller PJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
    Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
    Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
    Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
    Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
    Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
    J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.